Compare Invesco Ltd. (IVZ) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Ltd. vs Moderna, Inc. — how do they compare? Invesco Ltd. trades at $29.68 (market cap $13.15B), while Moderna, Inc. trades at $59.73 (market cap $23.60B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Invesco Ltd. pays a 2.9% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| IVZ | MRNA | |
|---|---|---|
Market Cap | $13.15B | $23.60B |
Sector | Financials | Health |
52-Week High | $30.30 | $81.80 |
52-Week Low | $20.20 | $22.36 |
Enterprise Value | $23.39B | $19.70B |
Dividend Yield | 2.9% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
